$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results
08:01pm, Thursday, 30'th Jul 2020
Conference call scheduled for today at 4:30 p.m. ET.ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discoverin
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call
11:30am, Thursday, 23'rd Jul 2020
Rockville, MD, July 23, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based
Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline
04:32pm, Wednesday, 22'nd Jul 2020
MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vident Investment Advisory LLC Takes $1.87 Million Position in MacroGenics Inc (NASDAQ:MGNX)
06:40am, Tuesday, 21'st Jul 2020
Vident Investment Advisory LLC bought a new stake in shares of MacroGenics Inc (NASDAQ:MGNX) in the 2nd quarter, HoldingsChannel reports. The firm bought 67,100 shares of the biopharmaceutical company
Contrasting MacroGenics (NASDAQ:MGNX) & Rhythm Pharmaceuticals (NASDAQ:RYTM)
01:12am, Tuesday, 14'th Jul 2020
MacroGenics (NASDAQ:MGNX) and Rhythm Pharmaceuticals (NASDAQ:RYTM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of t
Diversified Trust Co Makes New $307,000 Investment in MacroGenics Inc (NASDAQ:MGNX)
07:20am, Saturday, 11'th Jul 2020
Diversified Trust Co acquired a new stake in MacroGenics Inc (NASDAQ:MGNX) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
10:43pm, Thursday, 09'th Jul 2020
Rockville, MD, July 09, 2020 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal.
Here's Why MacroGenics Jumped 156.6% in the First Half of 2020
09:22pm, Thursday, 09'th Jul 2020
Investors remain optimistic that the leading drug candidate can earn marketing approval before the end of the year.
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
12:00am, Wednesday, 08'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
AbbVie Inc (NYSE: ABBV)...
Global Type 1 Diabetes Market Will Reach USD 2,800 Million by 2026: Facts & Factors
01:13pm, Wednesday, 01'st Jul 2020
Global type 1 diabetes market is expected to grow above a CAGR of 5.0% and is anticipated to reach over USD 2,800 Million by 2026.
Is MacroGenics Inc (MGNX) A Good Stock To Buy?
01:28am, Sunday, 28'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Sign In
Buy MGNX